Recent advancements in the field of diabetes treatment have introduced a revolutionary class of medications known as GLP-1 receptor agonists. These compounds work by mimicking the effects of glucagon-like peptide-1 https://siobhanmvyw566417.ivasdesign.com/62121257/novel-glp-1-receptor-agonists-semaglutide-tirzepatide-and-retatrutide